Skip to main content

Gisela Teixido i Tura

-

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca
Doctor
Cardiology
General Hospital

Gisela Teixido i Tura

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca
Doctor
Cardiology
General Hospital

-

-

Projects

Evalución de la eficiencia de la atorvastatina en la progresión de la dilatación aortica y la degenreacion valvular en pacientes con válvula aórtica bicúspide

IP: -
Collaborators: Gisela Teixido i Tura, Laura Galián Gay
Funding agency: Instituto de Salud Carlos III
Funding: 290400
Reference: ICI14/00197
Duration: 01/01/2015 - 30/06/2019

Heterogeneidad en la severidad de la afectación aórtica en el síndrome de Marfan. Predictores biomecánicos aórticos, biomarcadores y determinantes genéticos.

IP: -
Collaborators: Laura Gutierrez García-Moreno, Gisela Teixido i Tura, Laura Galián Gay
Funding agency: Instituto de Salud Carlos III
Funding: 174845
Reference: PI14/01062
Duration: 01/01/2015 - 30/06/2019

Patologia Cardiocirculatòria (GRC)

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Elsa Nieto Santa, Josep Pinar Sopena, Teresa González Alujas, Gisela Teixido i Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, AIDA RIBERA SOLÉ, Rosa María Lidón Corbi, Francesc Xavier Armengol Castells, Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno Garcia del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual, Laura Dos Subirá
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 65000
Reference: 2014 SGR 1572
Duration: 01/01/2014 - 31/12/2016

Red Cardiovascular

IP: -
Collaborators: Jorge Guillermo Romero Farina, José Antonio Barrabés Riu, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Josep Pinar Sopena, Teresa González Alujas, Gisela Teixido i Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Gemma Cuberas Borros, Rosa María Lidón Corbi, Francesc Xavier Armengol Castells, Vicens Serra Garcia, Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno Garcia del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual, Red Cardiovascular, Laura Dos Subirá, Maria Nazarena Pizzi
Funding agency: Instituto de Salud Carlos III
Funding: 668059.76
Reference: RD12/0042/0021
Duration: 01/01/2013 - 30/06/2017

Related news

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The study, with the participation of VHIR, will analyse the physiological response of the human body thanks to data collected by smartwatches and wearable devices.

Related professionals

Cleofé Romagosa Pérez-Portabell

Cleofé Romagosa Pérez-Portabell

Main researcher
Translational Molecular Pathology
Read more
Anna Abia Hereu

Anna Abia Hereu

Research technician
Multidisciplinary Nursing Research Group
Read more
Ingrid Galán Cartaña

Ingrid Galán Cartaña

Senior researcher
Clinical Neuroimmunology
Read more
Laura Grau de Diego

Laura Grau de Diego

Research technician
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.